Sign In
Latest updates on the coronavirus situation
×
ع
Quick links
Branches
Future Students
Future Faculty & Staff
Alumni
Job Opportunities
MyUOS
Faculty Directory
Libraries
UoS Mobile App
S E P
×
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
ع
Human Disease Biomarkers Discovery
Overview
Goals and Objectives
Our Team
Line of Research
Group Collaborators
Publications
Branches
Future Students
Future Faculty & Staff
Alumni
Job Opportunities
Navbar
Research
VC. for Research Office
Currently selected
Research Institute of Medical & Health Sciences
Research Institute of Sciences & Engineering
Research Institute of Humanities & Social Sciences
College of Graduate Studies
Research Funding Department
Scientific Publishing Unit
Technology Transfer Office
Research Outreach Department
For Researchers
New Researchers
Collaborate with researchers
Funding Opportunities
Facilities and Resources
Partnerships
Community Engagement
Our Partners
Research Collaboration
External grants procedures
Solar Decathlon Projects
Policies and Procedures
Outreach
Research Highlights
Research Newsletter
Research Cafe
Women in Research
Technical Exchange Meetings
Estedad Initiative
Research Events
Recognition Awards
Research Facts
Gallery
Videos
External Funding
Previous
Next
List 'Banner Items' does not exist at site with URL 'https://www.sharjah.ac.ae/en/Research/SIMHR/HDBD'.
Sharjah University
University of Sharjah
Research
Research Institute of Medical & Health Sciences
Human Disease Biomarkers Discovery
Goals and Objectives
Human Disease Biomarkers Discovery
Overview
Goals and Objectives
Our Team
Line of Research
Group Collaborators
Publications
Goals and Objectives
The main goal of this group is to thoroughly identify proteins/metabolites that result from alterations in biological processes associated with non-communicable diseases but also against important infectious diseases such as COVID-19
Contribute to a better understanding of the underlying mechanisms of diseases through the application of large-scale proteomics and metabolomics.
Optimization of large-scale data analysis and downstream computational, bioinformatics analysis and machine learning.
Consistently verification and translational of identified disease biomarkers through the application of MS-based quantitative measurements.
Developed qualified biomarkers warranty approved by the FDA
Identify new targets for drugs against non-communicable diseases but also against important infectious diseases such as COVID-19
Utilize qualified biomarker(s) to develop and test therapeutic agents against Human diseases
Development of immunochemistry/colorimetric products for a rapid detection of the qualified biomarkers
